- A slimming aid made from Hoodia cactus is set to be developed by Phytopharm and Unilever.
- Phytopharm will receive an initial fee of Â£6.5m from Unilever.
- Production of the Hoodia cactus at Phytopharm's nursery will rise from eight million plants to potentially hundreds of millions.
- The firm had initially hoped to market a slimming drug from Hoodia with Pfizer.
